Benzinga··PrnewswireScinai Immunotherapeutics Faces Nasdaq Delisting Risk After Price Breach
$SCNI warned by Nasdaq for trading below $1.00 for 30 consecutive days. Company has 180 days to restore compliance or face delisting.
SCNIimmunotherapyminimum bid price requirement